MONTREAL, Aug. 07, 2019  -- Osisko Metals Incorporated (the “Company” or “Osisko Metals”) (TSX-V: OM; OTCQX: OMZNF, FRANKFURT: 0B51) is pleased to announce preliminary flotation test work results from the Pine Point Project in the Northwest Territories, Canada. These results were obtained from testing representative drill core samples from the 2018-2019 definition drilling campaign that were pre-concentrated using an X-Ray Transmission (“XRT”) material sorter. The resulting concentrate was analyzed for lead and zinc as well as a suite of deleterious elements typically associated with smelter penalties.

 

Results from the optimized cleaner testwork are as follows:

 

Zinc recovery ranged between 93.1 to 94.5%

Lead recovery ranged from 87.4 to 91.4%

Zinc concentrate grade ranged between 63.6 to 64.1% Zn

Lead concentrate grade ranged between 67.9 to 72.1% Pb

Zinc concentrate is significantly below penalty thresholds for all deleterious impurities except MgO, which is at threshold limits

TORONTO and NEW YORK, Aug. 6, 2019 - Mountain Province Diamonds Inc. ("Mountain Province", or the "Company") (TSX and NASDAQ: MPVD) today announces its financial and operating results for the second quarter ("Q2 2019") and first half 2019 ("H1 2019") ended June 30, 2019.  All figures are expressed in Canadian dollars unless otherwise noted.

 

Operational Highlights for Second Quarter 2019 ("Q2 2019")

 

10,865,263 total tonnes mined in Q2 2019, 6% increase on comparable period (Q2 2018: 10,285,000). 

 

882,374 tonnes of ore treated in Q2 2019, 2% decrease from comparable quarter (Q2 2018: 899,000 tonnes). 

 

1,730,147 carats recovered at an average grade of 1.96 carats per tonne, 10% lower than comparable quarter (Q2 2018: 1,930,500 carats at 2.15 carats per tonne).  The grade variance year over year is mainly a function of mining lower grade ore tonnes in Q2 2019 from Hearne and SWC Kimberlites in comparison to higher grades from the 5034 Kimberlite in Q2 2018.  In addition, the ongoing plant modifications have, as expected, resulted in the removal of the very small, lowest value diamonds from the recovery process further contributing to fewer carats recovered.

VANCOUVER, British Columbia, Aug. 01, 2019 -- Asanko Gold Inc. (“Asanko” or the “Company”) (TSX, NYSE American: AKG)reports second quarter (“Q2”) 2019 operating and financial results for the Asanko Gold Mine (“AGM”), located in Ghana, West Africa. The AGM is a 50:50 joint venture (“JV”) with Gold Fields Ltd (JSE, NYSE: GFI), which is managed and operated by Asanko.  All amounts are in US dollars unless otherwise stated.

 

Q2 2019 Asanko Gold Mine Highlights (100% basis)

 

Record proceeds of $85.6 million generated from record gold sales of 66,337 ounces at an average realized price of $1,290 per ounce

 

Record gold production of 62,067 ounces, on track to meet 2019 production guidance

 

All-in sustaining cost1 (“AISC”) of $1,180/oz, with 2019 guidance of $1,040 – $1,060/oz maintained as AISC are expected to drop in Q4 2019 when the Nkran Cut 2 pushback has been substantially completed

 

Generated EBITDA1 of $35.2 million and operating cash flows before working capital changes of $35.3 million

 

Net income after tax of $13.6 million

VANCOUVER, British Columbia, July 24, 2019  -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have developed proprietary methods resulting in the achievement of the highest ∆9-tetrahydrocannabinol (“THC”) detection levels collected from human breath to date. Over the last several months, Company scientists have studied the unique chemical interactions of THC and cannabinoids in breath, and developed and evaluated novel methods to efficiently and practically capture and ionize THC and cannabinoid analytes collected from several different subjects. These analytes are typically found in extremely low quantities due to their relatively low volatilities, requiring an efficient sampling method.  The Company’s newly developed methods and technologies for sample capture are an important milestone and represent a significant advancement in the field of human breath studies. These novel capture methods could have implications for both point-of-care and lab-based instruments that would provide real-time results from breath samples, targeting analytes of a wide range of volatilities. The Company continues to expeditiously conduct trial testing to evaluate the sensitivity and accuracy of the instrument and to collect data to determine variance among test subjects at its Vancouver and Florida development facilities using its FAIMS (field asymmetric waveform ion mobility spectrometry) THC detection device.